407 related articles for article (PubMed ID: 25975562)
1. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.
Chen JF; Ho H; Lichterman J; Lu YT; Zhang Y; Garcia MA; Chen SF; Liang AJ; Hodara E; Zhau HE; Hou S; Ahmed RS; Luthringer DJ; Huang J; Li KC; Chung LW; Ke Z; Tseng HR; Posadas EM
Cancer; 2015 Sep; 121(18):3240-51. PubMed ID: 25975562
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells in prostate cancer: Does (nuclear) size matter?
Pal SK; Agarwal N; Jones JO
Cancer; 2015 Sep; 121(18):3190-2. PubMed ID: 25980931
[No Abstract] [Full Text] [Related]
3. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
4. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells.
Lin M; Chen JF; Lu YT; Zhang Y; Song J; Hou S; Ke Z; Tseng HR
Acc Chem Res; 2014 Oct; 47(10):2941-50. PubMed ID: 25111636
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V
Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381
[TBL] [Abstract][Full Text] [Related]
6. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.
Shao C; Liao CP; Hu P; Chu CY; Zhang L; Bui MH; Ng CS; Josephson DY; Knudsen B; Tighiouart M; Kim HL; Zhau HE; Chung LW; Wang R; Posadas EM
PLoS One; 2014; 9(2):e88967. PubMed ID: 24551200
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
8. Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancer.
Yao N; Jan YJ; Cheng S; Chen JF; Chung LW; Tseng HR; Posadas EM
Am J Clin Exp Urol; 2018; 6(2):43-54. PubMed ID: 29666832
[TBL] [Abstract][Full Text] [Related]
9. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
[TBL] [Abstract][Full Text] [Related]
10. The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer.
Dong L; Zhang Z; Smith K; Kuczler MD; Reyes D; Amend SR; Cho YK; Xue W; Pienta KJ
BJU Int; 2020 Jul; 126(1):191-201. PubMed ID: 32115854
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.
Goodman OB; Symanowski JT; Loudyi A; Fink LM; Ward DC; Vogelzang NJ
Clin Genitourin Cancer; 2011 Sep; 9(1):31-8. PubMed ID: 21705286
[TBL] [Abstract][Full Text] [Related]
12. Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients.
Mendelaar PAJ; Kraan J; Van M; Zeune LL; Terstappen LWMM; Oomen-de Hoop E; Martens JWM; Sleijfer S
Mol Oncol; 2021 Jan; 15(1):116-125. PubMed ID: 32949099
[TBL] [Abstract][Full Text] [Related]
13. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
[TBL] [Abstract][Full Text] [Related]
14. NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells.
Jan YJ; Chen JF; Zhu Y; Lu YT; Chen SH; Chung H; Smalley M; Huang YW; Dong J; Chen LC; Yu HH; Tomlinson JS; Hou S; Agopian VG; Posadas EM; Tseng HR
Adv Drug Deliv Rev; 2018 Feb; 125():78-93. PubMed ID: 29551650
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating tumor cells in different stages of prostate cancer.
Thalgott M; Rack B; Maurer T; Souvatzoglou M; Eiber M; Kreß V; Heck MM; Andergassen U; Nawroth R; Gschwend JE; Retz M
J Cancer Res Clin Oncol; 2013 May; 139(5):755-63. PubMed ID: 23358719
[TBL] [Abstract][Full Text] [Related]
16. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer.
Amato RJ; Melnikova V; Zhang Y; Liu W; Saxena S; Shah PK; Jensen BT; Torres KE; Davis DW
Urology; 2013 Jun; 81(6):1303-7. PubMed ID: 23622774
[TBL] [Abstract][Full Text] [Related]
17. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.
Cann GM; Gulzar ZG; Cooper S; Li R; Luo S; Tat M; Stuart S; Schroth G; Srinivas S; Ronaghi M; Brooks JD; Talasaz AH
PLoS One; 2012; 7(11):e49144. PubMed ID: 23145101
[TBL] [Abstract][Full Text] [Related]
18. NanoVelcro Chip for CTC enumeration in prostate cancer patients.
Lu YT; Zhao L; Shen Q; Garcia MA; Wu D; Hou S; Song M; Xu X; Ouyang WH; Ouyang WW; Lichterman J; Luo Z; Xuan X; Huang J; Chung LW; Rettig M; Tseng HR; Shao C; Posadas EM
Methods; 2013 Dec; 64(2):144-52. PubMed ID: 23816790
[TBL] [Abstract][Full Text] [Related]
19. Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups.
Awe JA; Saranchuk J; Drachenberg D; Mai S
Urol Oncol; 2017 May; 35(5):300-309. PubMed ID: 28202223
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
